A share price of Hologic, Inc [HOLX] is currently trading at $74.14, down -0.01%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HOLX shares have lost -0.22% over the last week, with a monthly amount glided 6.14%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hologic, Inc [NASDAQ: HOLX] stock has seen the most recent analyst activity on October 07, 2025, when Evercore ISI upgraded its rating to an Outperform but kept the price target unchanged to $78 for it. Previously, Argus upgraded its rating to Buy on August 18, 2025, and kept the price target unchanged to $80. On August 06, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $87 on the stock. Citigroup upgraded its rating to a Buy but stick to its price target of $80 on July 09, 2025. Needham reiterated its recommendation of a Hold. Argus downgraded its rating to Hold for this stock on March 03, 2025. In a note dated February 06, 2025, Leerink Partners downgraded an Market Perform rating on this stock and revised its target price from $80 to $75.
Hologic, Inc experienced fluctuations in its stock price throughout the past year between $51.90 and $80.31. Currently, Wall Street analysts expect the stock to reach $77.5 within the next 12 months. Hologic, Inc [NASDAQ: HOLX] shares were valued at $74.14 at the most recent close of the market. An investor can expect a potential return of 4.53% based on the average HOLX price forecast.
Analyzing the HOLX fundamentals
Trailing Twelve Months sales for Hologic, Inc [NASDAQ:HOLX] were 4.10B which represents 6.24% growth. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.12 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.08 points at the first support level, and at 74.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 74.23, and for the 2nd resistance point, it is at 74.33.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hologic, Inc [NASDAQ:HOLX] is 3.75. Also, the Quick Ratio is 3.06, while the Cash Ratio stands at 2.01. Considering the valuation of this stock, the price to sales ratio is 4.02, the price to book ratio is 3.40 and price to earnings (TTM) ratio is 29.85.
Transactions by insiders
Recent insider trading involved Stamoulis Christiana, Director, that happened on Oct 20 ’25 when 7402.0 shares were sold. Director, Stamoulis Christiana completed a deal on Oct 20 ’25 to buy 7402.0 shares. Meanwhile, Chairman, President and CEO MACMILLAN STEPHEN P sold 0.14 million shares on Sep 22 ’25.
